The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 173 results:
Author Title Type [ Year(Asc)]
Filters: Author is Roilides, Emmanuel  [Clear All Filters]
2012
Iosifidis, E., Farmaki E., Nedelkopoulou N., Tsivitanidou M., Kaperoni M., Pentsoglou V., et al. (2012).  Outbreak of bloodstream infections because of Serratia marcescens in a pediatric department.. Am J Infect Control. 40(1), 11-5.
Meletiadis, J., Al-Saigh R., Velegraki A., Walsh T. J., Roilides E., & Zerva L. (2012).  Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.. Antimicrob Agents Chemother. 56(1), 403-10.
Katragkou, A., Tsikopoulou F., Roilides E., & Zaoutis T. E. (2012).  Posaconazole: when and how? The clinician's view.. Mycoses. 55(2), 110-22.
Steinbach, W. J., Roilides E., Berman D., Hoffman J. A., Groll A. H., Bin-Hussain I., et al. (2012).  Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.. Pediatr Infect Dis J. 31(12), 1252-7.
Gamaletsou, M. N., Sipsas N. V., Roilides E., & Walsh T. J. (2012).  Rhino-orbital-cerebral mucormycosis.. Curr Infect Dis Rep. 14(4), 423-34.
2011
Chatzimoschou, A., Katragkou A., Simitsopoulou M., Antachopoulos C., Georgiadou E., Walsh T. J., et al. (2011).  Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.. Antimicrob Agents Chemother. 55(5), 1968-74.
Katragkou, A., Chatzimoschou A., Simitsopoulou M., Georgiadou E., & Roilides E. (2011).  Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.. J Antimicrob Chemother. 66(3), 588-91.
Turkova, A., Roilides E., & Sharland M. (2011).  Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?. Curr Opin Infect Dis. 24(2), 163-71.
Saoulidis, S., Simitsopoulou M., Dalakiouridou M., Walsh T. J., L Wheat J., Papaioannidou P., et al. (2011).  Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.. Mycoses. 54(5), e486-92.
Kollios, K., Tsolaki A., Antachopoulos C., Moix I., Morris M. A., Papadopoulou M., et al. (2011).  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl.. J Pediatr Endocrinol Metab. 24(7-8), 599-601.
Simitsopoulou, M., Roilides E., Georgiadou E., Paliogianni F., & Walsh T. J. (2011).  Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.. Med Mycol. 49(2), 176-85.
Katragkou, A., Simitsopoulou M., Chatzimoschou A., Georgiadou E., Walsh T. J., & Roilides E. (2011).  Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells.. Cytokine. 55(3), 330-4.
Koukou, D., Grivea I., Roma E., Tsioni H., Trimis G., Galanakis E., et al. (2011).  Frequency, clinical characteristics, and genotype distribution of rotavirus gastroenteritis in Greece (2007-2008).. J Med Virol. 83(1), 165-9.
Simitsopoulou, M., Roilides E., & Walsh T. J. (2011).  Immunomodulatory properties of antifungal agents on phagocytic cells.. Immunol Invest. 40(7-8), 809-24.
Roilides, E. (2011).  Invasive candidiasis in neonates and children.. Early Hum Dev. 87 Suppl 1, S75-6.
Dotis, J., & Roilides E. (2011).  Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature.. Mycoses. 54(6), e686-96.
Pana, Z. Dorothea, & Roilides E. (2011).  Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma.. Pediatr Blood Cancer. 57(1), 30-5.
Maltezou, H. C., Katerelos P., Mavrouli M., Lourida A., Routsias J. G., Spanakis N., et al. (2011).  Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.. Vaccine. 29(38), 6664-9.
Stergiopoulou, T., Meletiadis J., Sein T., Papaioannidou P., Walsh T. J., & Roilides E. (2011).  Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.. Antimicrob Agents Chemother. 55(12), 5923-9.
Maertens, J., Groll A. H., Cordonnier C., de la Cámara R., Roilides E., & Marchetti O. (2011).  Treatment and timing in invasive mould disease.. J Antimicrob Chemother. 66 Suppl 1, i37-43.
Antachopoulos, C., Stergiopoulou T., Simitsopoulou M., Georgiadou E., Kottas S., Marinopoulos D., et al. (2011).  Ventriculitis caused by Aspergillus fumigatus in a child with central nervous system tuberculosis.. Mycoses. 54(5), e627-30.
2010
Tsitsopoulos, P. P., Iosifidis E., Antachopoulos C., Tsivitanidou M., Anagnostopoulos I., Roilides E., et al. (2010).  A 5-year epidemiological study of nosocomial bloodstream infections in a neurosurgery department.. Infect Control Hosp Epidemiol. 31(4), 414-7.
Mouloudi, E., Protonotariou E., Zagorianou A., Iosifidis E., Karapanagiotou A., Giasnetsova T., et al. (2010).  Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.. Infect Control Hosp Epidemiol. 31(12), 1250-6.
Iosifidis, E., Antachopoulos C., Ioannidou M., Mitroudi M., Sdougka M., Drossou-Agakidou V., et al. (2010).  Colistin administration to pediatric and neonatal patients.. Eur J Pediatr. 169(7), 867-74.
Demchok, J. P., Meletiadis J., Roilides E., & Walsh T. J. (2010).  Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.. Mycoses. 53(3), 239-45.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.